Amino Collective — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Nostosnostos-genomics.comin𝕏Feb 2022
Nostos Genomics develops genetic testing interpretation tools to improve the accuracy, speed, and accessibility of variant analysis for patients with rare and genetic diseases.
AI & Machine LearningBiotechDigital HealthHealthtechBerlin, DE
David Gorgan(Founder)inRocio Acuna Hidalgo(CTO)in
Co-investors42CAPAcequia Capital (AceCap)Entrepreneur FirstFaberFrontline Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.